ABT vs STEX · P/E 25, rev $44.33B vs rev $146.0K
Abbott Laboratories (ABT) versus Streamex Corp (STEX) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Streamex Corp (STEX) is a capital markets company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported STEX revenue for 2026-06-30 was $146.0K. Net income was -$61.2M. STEX currently screens at market cap $216.5M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. STEX currently screens at market cap $216.5M.
Not investment advice. Open the ABT and STEX stock pages for the full models.
Not investment advice.